Brief: Shattuck Labs - As Of Sept 30, 2023, Cash And Cash Equivalents And Investments $101.1 Million
09/11/2023 11:20
Nov 9 (Reuters) - Shattuck Labs Inc STTK.O :
* SHATTUCK LABS INC - AS OF SEPTEMBER 30, 2023, CASH AND
CASH
EQUIVALENTS AND INVESTMENTS WERE $101.1 MILLION
* SHATTUCK LABS-SEES CASH,CASH EQUIVALENTS,INVESTMENTS
SUFFICIENT
TO FUND OPERATIONS VIA YEAR-END 2024,BEYOND RESULTS FROM PHASE 1
CLINICAL TRIALS OF SL-172154
Source text for Eikon: ID:nGNX23qCNY
Further company coverage: STTK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shattuck Labs
See all newsBrief: Shattuck Labs Announces Phase 2 Clinical Trial Of Sl-325 In Hidradenitis Suppurativa And Appointment Of Shoba Ravichandran, M.D., As Senior Vice President, Clinical Development
Shattuck Labs Inc reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
U.S. STOCKS ON THE MOVE-Duke Energy, Sea, Cardinal Health